Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018 2019

Details for Mechanism ID: 17832
Country/Region: South Sudan
Year: 2018
Main Partner: Catholic Medical Mission Board
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $2,146,335 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $35,406
Care: Pediatric Care and Support (PDCS) $123,920
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $743,520
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $376,048
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $778,927
Treatment: Pediatric Treatment (PDTX) $88,514
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST 25-29, Female, Negative 2019 4,889
HTS_TST 25-29, Female, Negative 2019 12,066
HTS_TST 25-29, Female, Negative 2019 458
HTS_TST 25-29, Female, Negative 2019 1,142
HTS_TST 25-29, Female, Negative 2019 196
HTS_TST 25-29, Female, Negative 2019 2,392
HTS_TST 25-29, Male, Negative 2019 12
HTS_TST 25-29, Male, Negative 2019 7,764
HTS_TST 25-29, Male, Negative 2019 231
HTS_TST 25-29, Male, Negative 2019 702
HTS_TST 25-29, Male, Negative 2019 102
HTS_TST 25-29, Male, Negative 2019 2,204
HTS_TST 30-34, Female, Negative 2019 2,591
HTS_TST 30-34, Female, Negative 2019 4,889
HTS_TST 30-34, Female, Negative 2019 12
HTS_TST 30-34, Female, Negative 2019 9,431
HTS_TST 30-34, Female, Negative 2019 269
HTS_TST 30-34, Female, Negative 2019 973
HTS_TST 30-34, Female, Negative 2019 39
HTS_TST 30-34, Male, Negative 2019 1,126
HTS_TST 30-34, Male, Negative 2019 10
HTS_TST 30-34, Male, Negative 2019 1,730
HTS_TST 30-34, Male, Negative 2019 122
HTS_TST 30-34, Male, Negative 2019 451
HTS_TST 30-34, Male, Negative 2019 39
HTS_TST 35-39, Female, Negative 2019 25
HTS_TST 35-39, Female, Negative 2019 326
HTS_TST 35-39, Female, Negative 2019 802
HTS_TST 35-39, Female, Negative 2019 86
HTS_TST 35-39, Female, Negative 2019 39
HTS_TST 35-39, Male, Negative 2019 53
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 115,702
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 52
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 39
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 156
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 117
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2019 1,630
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 1,608
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 2,965
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 19
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2019 20
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 180
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 153
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 87
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 90
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 47
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 215
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 152
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 38
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 64
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2019 145
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 382
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 199
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 178
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 395
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 166
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 988
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 420
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 42
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 52
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 1,782
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 415
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 323
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 1,792
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 1,092
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 2,131
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 1,859
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 557
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 560
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 517
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2019 6
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 1
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 2
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 2
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 2
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 2
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 6
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 2
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 4
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2019 183
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 3,437
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 2,424
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 1,935
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 6,287
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 2,695
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 6,431
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 5,385
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 2,411
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 1,486
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2019 319
HTS_TST_POS 25-29, Female, Positive 2019 79
HTS_TST_POS 25-29, Female, Positive 2019 899
HTS_TST_POS 25-29, Female, Positive 2019 53
HTS_TST_POS 25-29, Female, Positive 2019 63
HTS_TST_POS 25-29, Female, Positive 2019 24
HTS_TST_POS 25-29, Female, Positive 2019 81
HTS_TST_POS 25-29, Male, Positive 2019 7
HTS_TST_POS 25-29, Male, Positive 2019 676
HTS_TST_POS 25-29, Male, Positive 2019 40
HTS_TST_POS 25-29, Male, Positive 2019 42
HTS_TST_POS 25-29, Male, Positive 2019 13
HTS_TST_POS 25-29, Male, Positive 2019 72
HTS_TST_POS 30-34, Female, Positive 2019 80
HTS_TST_POS 30-34, Female, Positive 2019 79
HTS_TST_POS 30-34, Female, Positive 2019 7
HTS_TST_POS 30-34, Female, Positive 2019 602
HTS_TST_POS 30-34, Female, Positive 2019 43
HTS_TST_POS 30-34, Female, Positive 2019 73
HTS_TST_POS 30-34, Female, Positive 2019 5
HTS_TST_POS 30-34, Male, Positive 2019 28
HTS_TST_POS 30-34, Male, Positive 2019 6
HTS_TST_POS 30-34, Male, Positive 2019 221
HTS_TST_POS 30-34, Male, Positive 2019 32
HTS_TST_POS 30-34, Male, Positive 2019 34
HTS_TST_POS 30-34, Male, Positive 2019 5
HTS_TST_POS 35-39, Female, Positive 2019 4
HTS_TST_POS 35-39, Female, Positive 2019 65
HTS_TST_POS 35-39, Female, Positive 2019 6
HTS_TST_POS 35-39, Female, Positive 2019 5
HTS_TST_POS 35-39, Male, Positive 2019 5
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 6
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 19
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 15
HTS_TST_POS Service Delivery Point (Facility) ANC: 10-14, Positive 2019 26
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 27
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 48
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 20
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 12
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 10
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 10
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 17
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 24
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 25
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 28
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 48
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 20
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 24
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 60
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 31
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 77
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 64
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 19
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 17
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 13
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) VCT: <1, Positive 2019 10
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 206
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 91
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 61
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 328
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 82
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 508
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 243
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 173
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 108
PMTCT_ART Already on ART at beginning of current pregnancy 2019 1,043
PMTCT_ART New on ART 2019 719
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 1,762
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 18,157
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 1,035
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 726
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 1,761
PMTCT_EID Sum of Infant Age disaggregates 2019 1,761
PMTCT_STAT 25-29, Female 2019 8,615
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 616
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 8,005
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 92
PMTCT_STAT 30-34, Female 2019 4,154
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 623
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 3,229
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 94
PMTCT_STAT 35-39, Female 2019 70
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 80
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 55
PMTCT_STAT 40-49, Female 2019 22
PMTCT_STAT By Age (Numerator): 10-14 2019 180
PMTCT_STAT By Age (Numerator): 15-19 2019 1,703
PMTCT_STAT By Age (Numerator): 20-24 2019 3,227
PMTCT_STAT By Age (Numerator): Unknown Age 2019 8
PMTCT_STAT By Number of known positives: 10-14 2019 2
PMTCT_STAT By Number of known positives: 15-19 2019 79
PMTCT_STAT By Number of known positives: 20-24 2019 158
PMTCT_STAT By Number of new negative: 10-14 2019 192
PMTCT_STAT By Number of new negative: 15-19 2019 1,619
PMTCT_STAT By Number of new negative: 20-24 2019 3,017
PMTCT_STAT By Number of new positives: 15-19 2019 18
PMTCT_STAT By Number of new positives: 20-24 2019 57
PMTCT_STAT Number of new ANC and L&D clients 2019 19,114
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 18,157
PMTCT_STAT_den 25-29, Female 2019 6,853
PMTCT_STAT_den 30-34, Female 2019 5,735
PMTCT_STAT_den 35-39, Female 2019 1,425
PMTCT_STAT_den By Age (Denominator): <15-19 2019 1,739
PMTCT_STAT_den By Age (Denominator): 10-14 2019 75
PMTCT_STAT_den By Age (Denominator): 20-24 2019 3,287
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 38
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 23
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 61
TB_PREV Alternative TPT Regimen, Life-long ART, Already, Positive 2019 12
TB_PREV Alternative TPT Regimen, Life-long ART, New, Positive 2019 352
TB_PREV By Age/Sex (Numerator): <15, Female 2019 12
TB_PREV By Age/Sex (Numerator): <15, Male 2019 176
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 352
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 633
TB_PREV IPT, Life-long ART, Already, Positive 2019 176
TB_PREV IPT, Life-long ART, New, Positive 2019 633
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 1,173
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 3,910
TB_PREV_den Alternative TPT Regimen, Life-long ART, Already, Positive 2019 39
TB_PREV_den Alternative TPT Regimen, Life-long ART, New, Positive 2019 1,173
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 39
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 587
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 1,173
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 2,111
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 587
TB_PREV_den IPT, Life-long ART, New, Positive 2019 2,111
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 6
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 27
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 12
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 74
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 121
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 121
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 3
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 16
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 5
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 40
TX_CURR 25-29, Female, Positive 2019 3,445
TX_CURR 25-29, Male, Positive 2019 2,316
TX_CURR 30-34, Female, Positive 2019 2,229
TX_CURR 30-34, Male, Positive 2019 1,429
TX_CURR 35-39, Female, Positive 2019 713
TX_CURR 35-39, Male, Positive 2019 467
TX_CURR 40-49, Female, Positive 2019 514
TX_CURR 40-49, Male, Positive 2019 347
TX_CURR Age/Sex: <1 2019 84
TX_CURR Age/Sex: <1-9 2019 281
TX_CURR Age/Sex: 10-14 Female 2019 338
TX_CURR Age/Sex: 10-14 Male 2019 226
TX_CURR Age/Sex: 15-19 Female 2019 359
TX_CURR Age/Sex: 15-19 Male 2019 230
TX_CURR Age/Sex: 20-24 Female 2019 1,001
TX_CURR Age/Sex: 20-24 Male 2019 658
TX_CURR Age/Sex: 50+ Female 2019 264
TX_CURR Age/Sex: 50+ Male 2019 245
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 15,146
TX_CURR Sum of age/sex disaggregates 2019 589
TX_NEW 25-29, Female, Positive 2019 1,090
TX_NEW 25-29, Male, Positive 2019 1,062
TX_NEW 30-34, Female, Positive 2019 637
TX_NEW 30-34, Male, Positive 2019 622
TX_NEW 35-39, Female, Positive 2019 632
TX_NEW 35-39, Male, Positive 2019 444
TX_NEW 40-49, Female, Positive 2019 201
TX_NEW 40-49, Male, Positive 2019 203
TX_NEW Breastfeeding status 2019 37
TX_NEW By Age/Sex: <1 2019 56
TX_NEW By Age/Sex: 1-9 2019 70
TX_NEW By Age/Sex: 10-14 Female 2019 235
TX_NEW By Age/Sex: 10-14 Male 2019 129
TX_NEW By Age/Sex: 15-19 Female 2019 60
TX_NEW By Age/Sex: 15-19 Male 2019 41
TX_NEW By Age/Sex: 20-24 Female 2019 519
TX_NEW By Age/Sex: 20-24 Male 2019 383
TX_NEW By Age/Sex: 50+ Female 2019 109
TX_NEW By Age/Sex: 50+ Male 2019 13
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 6,506
TX_NEW Pregnancy status 2019 934
TX_NEW Sum of Age/Sex disaggregates 2019 1,489
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 9,540
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 190
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 96
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 4,771
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 4,484
TX_PVLS_den Denominator: Indication: Routine 2019 9,540
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 153
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 130
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 2,321
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 1,348
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 3,952
TX_RET Numerator by Status: Breastfeeding 2019 190
TX_RET Numerator by Status: Pregnant 2019 174
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 4,456
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 171
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 144
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 2,628
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 1,319
TX_RET_den Denominator by Status: Breastfeeding 2019 79
TX_RET_den Denominator by Status: Pregnant 2019 184
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 7,825
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 202
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 186
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 4,304
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 3,134
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 7,825
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 7,825
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 783
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 3,913
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 1,565
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 1,565